Primary LBO of ACS with GENEO
P
Paris (France), 26 January 2024,
Financière de Courcelles advised ACS shareholders in the context of primary LBO with GENEO Capital Entrepreneur. This operation will enable a new growth phase for this insurance broker specialized in international mobility and health of travelers and expatriates.
GENEO’s investment in the company will accelerate recruitment of key managers, the digitalization, and the external growth in France and abroad.
Founded in 1979 by Didier Da Rin, ACS is the trusted companion of travelers and expatriates worldwide, whatever the nature and duration of their stay abroad, by offering a wide range of international health insurance and assistance solutions. A major player in the French travel and expatriate health insurance industry, ACS also assists the diplomatic corps with all their insurance issues, as well as impatriates, with an insurance policy dedicated to repatriation assistance.
ACS has positioned itself as a specialist with expertise across the entire value chain, from product design and distribution to claims management and compensation. The company distributes its insurance products directly or through its network of 400 partner brokers and business providers, for its clients based in 190 countries in the world.
Edouard Da Rin, ACS Managing Director : « We are extremely enthusiastic about embarking on this new stage in ACS’s development with GENEO, and we are convinced that GENEO, as an “evergreen” investment company, with its experience in the SME sector, particularly family-owned, will be the ideal partner to help us realize our many projects aimed at achieving growth that reconciles meaning and performance, thanks to its operational support and flexible approach. It was important for ACS to find a partner that would go beyond mere financial ties, who would be able to fully understand our needs and share our values. The whole ACS team welcomes GENEO! »
Marc Dupuy, Managing Partner of GENEO Capital Entrepreneur : « We’re both delighted to have been chosen by Didier and Edouard Da Rin, and excited to support a family-run, market-leading SME in this new stage of its development. As a key player in its field for over 45 years, we are fully mobilized to meet ACS’s growth challenges, particularly in terms of structuring its governance and management structure, and the implementation of an extremely clear external growth strategy. We are also delighted to welcome ACS to our Community of Long-Term Builders. »
Christophe Brière and Michael Petit, Managing Partner and Managing Director of Financière de Courcelles : « This LBO represents a key step in ACS’s development, and should enable the company to continue the strong growth seen over the past 15 years. The project aroused a great deal of interest, and management had a choice between several very well-constructed projects. GENEO’s teams made the difference, and we’re delighted with this long-term partnership.»
Financière de Courcelles FIG team is delighted to have supported ACS shareholders in this primary LBO operation and confirms is strong dynamic in the financial services sector.
STAKEHOLDERS IN THE OPERATION
ACS side :
- Company : ACS (Didier Da Rin, Edouard Da Rin)
- M&A advisor : Financière de Courcelles (Christophe Brière, Michael Petit, Charles Delbarre, Yanis Alaoui)
- Legal advisor : Valther Avocats (Idris Hebbat, Thibault Germain, Patrick Hannan)
- Financial Due Diligence : Oderis (Julien Passerat, Antoine Chanut)
GENEO side :
- Investor : Geneo Capital Entrepreneur (Marc Dupuy, Antoine Riley)
- M&A advisor : Newco (Alexandre Gebelin, Manuel Le Guen)
- Legal advisor : SVZ (Pierre-Emmanuel Chevalier, Natacha Baratier, Enora Floury)
- Financial Due Diligence: 8 Advisory (Emmanuel Riou, Arthur Croiset)
Financing :
- Caisse d’Epargne Ile-de-France (Cédric Alin, Paul Morigny, Steven Neveu)
- Société Générale (Delphine Kaptan, Hakim Kadi, Arno Pingray)
- BNP Paribas (Benoît Monteil, Amine Achour, Delphine Louvet)
< Our transactions